Clinical Trials

RECRUITING
Pancreatic Cancer Detection Consortium
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Conditions:
Pancreatic Cancer Pancreatic Carcinoma Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma
9 more conditions available...
Locations:
📍 Phoenix, Arizona, United States
📍 Scottsdale, Arizona, United States
📍 Monrovia, California, United States
📍 Newport Beach, California, United States
7 more locations available...
RECRUITING
A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005)
The purpose of this study is to assess the safety and efficacy of V940 in combination with pembrolizumab (MK-3475) compared to pembrolizumab alone as ...
Conditions:
Bladder Cancer
Locations:
📍 Orlando, Florida, United States
📍 Philadelphia, Pennsylvania, United States
📍 Houston, Texas, United States
📍 Macquarie University, New South Wales, Australia
31 more locations available...
RECRUITING
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposi...
Conditions:
Angioimmunoblastic T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Follicular T-Cell Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
3 more conditions available...
Locations:
📍 Duarte, California, United States
📍 La Jolla, California, United States
📍 Los Angeles, California, United States
📍 Washington, District of Columbia, United States
65 more locations available...
RECRUITING
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
Participants are invited to take part in this research study because they have relapsed (cancer has come back) or refractory (cancer has not responded...
Conditions:
Lymphoma, B-Cell Relapsed Cancer Refractory Lymphoma Diffuse Large B Cell Lymphoma
4 more conditions available...
Locations:
📍 Boston, Massachusetts, United States
📍 Boston, Massachusetts, United States
RECRUITING
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
The purpose of the study is to see if the combination of radiation therapy and cemiplimab immunotherapy is an effective treatment for people with loca...
Conditions:
Cutaneous Squamous Cell Carcinoma Skin Cancer Squamous Cell Carcinoma Locally Advanced Squamous Cell Carcinoma
3 more conditions available...
Locations:
📍 Aurora, Colorado, United States
📍 Tampa, Florida, United States
📍 Basking Ridge, New Jersey, United States
📍 Middletown, New Jersey, United States
9 more locations available...
RECRUITING
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
Researchers are looking for a way to treat classical Hodgkin lymphoma (cHL) that is relapsed (the cancer has come back after treatment) or refractory ...
Conditions:
Hodgkin Lymphoma
Locations:
📍 Tucson, Arizona, United States
📍 Los Angeles, California, United States
📍 Lexington, Kentucky, United States
📍 Baltimore, Maryland, United States
88 more locations available...
RECRUITING
Combination of TATE and PD-1 Inhibitor in Liver Cancer
This is a multi-center, open-label phase IIA study that investigates the preliminary efficacy of Trans-arterial Tirapazamine Embolization (TATE) treat...
Conditions:
Hepatocellular Carcinoma Gastric Cancer
Locations:
📍 Orange, California, United States
📍 Oklahoma City, Oklahoma, United States
📍 Milwaukee, Wisconsin, United States
RECRUITING
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Particip...
Conditions:
Localized Prostate Cancer
Locations:
📍 Los Angeles, California, United States
📍 Glenview, Illinois, United States
📍 New York, New York, United States
RECRUITING
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
This phase II trial evaluates lenvatinib for the treatment of hepatocellular carcinoma (HCC) that has come back (recurrent) after a liver transplant. ...
Conditions:
Recurrent Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v8
4 more conditions available...
Locations:
📍 Birmingham, Alabama, United States
📍 Scottsdale, Arizona, United States
📍 Atlanta, Georgia, United States
RECRUITING
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
This is a clinical trial in patients with advanced hepatocellular carcinoma (HCC) and Child-Pugh Class B7 (CPB7) cirrhosis whose disease has progresse...
Conditions:
Hepatocellular Carcinoma Cirrhosis
Locations:
📍 Dallas, Texas, United States
📍 Banja Luka, Bosnia and Herzegovina
📍 Mostar, Bosnia and Herzegovina
📍 Sarajevo, Bosnia and Herzegovina
28 more locations available...
RECRUITING
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income...
Conditions:
HIV Cervical Cancer
Locations:
📍 La Jolla, California, United States
📍 Enugu, Nigeria
RECRUITING
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
This clinical study aims to assess feasibility, safety, tolerability, and compliance of a Nonessential Amino Acid Restriction (NEAAR) medical food in ...
Conditions:
Rectal Cancer
Locations:
📍 Tampa, Florida, United States
RECRUITING
A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
The study has 2 parts. The first part is open to adults with different types of advanced cancer (solid tumours with changes in the HER2 gene) for whom...
Conditions:
Neoplasm Metastasis Non-Small Cell Lung Cancer
Locations:
📍 Birmingham, Alabama, United States
📍 Beverly Hills, California, United States
📍 Duarte, California, United States
📍 Huntington Beach, California, United States
80 more locations available...
RECRUITING
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
The aim of this study is to potentiate adaptive immunity to enhance the anti-tumor activity of anti-PD1 antibody by the addition of anti-CTLA4 antibod...
Conditions:
Head and Neck Squamous Cell Carcinoma (HNSCC)
Locations:
📍 Pittsburgh, Pennsylvania, United States
RECRUITING
Second Window Indocyanine Green for All Nervous System Tumors
The study is being conducted to determine if a same-day, low-dose intravenous (into a vein) injection of indocyanine green (ICG) (FDA-approved dye) be...
Conditions:
Nervous System Tumor
Locations:
📍 Philadelphia, Pennsylvania, United States

Total Trials: 61 - 75 of 6772